A total of 7.6 million doses will come from AstraZeneca – enough for 3.8 million people, and 10.72 million doses from Novavax – enough for 5.36 million people. Both vaccines require two doses to be administered.
The government already has to pre-purchase agreements for 750,000 courses from Pfizer/BioNTech and 5 million from Janssen.